Clinical Trials Directory

Trials / Completed

CompletedNCT04173923

Long Term Follow-up of Cervical Myelopathy Inpatients Treated With Integrated Complementary and Alternative Medicine

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Jaseng Medical Foundation · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Model of this study is a combined both retrospective chart review and follow up survey. Data of 4 hospitals will be used to find out the efficacy of conservative treatment in cervical myelopathy.

Detailed description

Cervical myelopathy is known as Its symptoms are progressively worsened, and there are only a small amount of positive outcomes other than surgery. However, as with other spinal and nerve disorders, non-surgical treatments are getting more attention in terms of patient safety, and because they provide patients with more choice in treatment than in terms of surgical treatment, they can provide closer approach to patient-centered care. Physical therapy and medication are well known for the currently known non-surgical and conservative treatments, but research reported on the treatment of cervical myelopathy by using Korean medicine treatment so far has its weak level. Therefore, it is expected that this study will demonstrate the efficacy of the treatment of cervical myelopathy in Korean medicine treatment and will further pave the way for non-surgical treatment of spinal myelopathy. Therefore, The investigators conducted observational trial to analyze the effectiveness of Korean medicine treatment in spinal myelopathy. Retrospective data will be extracted using electronic medical records and computerized data of hospitalized patients. Based on this, investigators will conduct research in the form of prospective survey and analyze the causal relationship and factors using the two data. The hospital's medical records will be used to analyze the patient's condition during the hospitalization period and to determine the situation after the end of treatment through questionnaire. The questionnaire will be developed after consultation with experts from musculoskeletal system and related societies, and will be used for the questionnaire.

Conditions

Interventions

TypeNameDescription
DRUGHerbal medicineHerbal medicine will be administered in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum,Eucommia ulmoides, canthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, aposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycinemax, Atractylodes japonica) at the physician's discretion.
PROCEDUREChuna manual medicineChuna is a Korean manual therapy directed at the spine and joints that incorporates various spinal manual medicine techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manual medicine will be administered to the pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.
PROCEDUREPharmacopuncturePharmacopuncture consisting of select herbal ingredients will be administered at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea) at the physician's discretion.
PROCEDUREAcupunctureAcupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDUREElectroacupunctureElectroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDURECuppingCupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.
PROCEDUREOther intervention(s)Patients will be allowed any other additional intervention(s) as deemed necessary regardless of type or dose, and patterns of use will be investigated and recorded as a pragmatic clinical study.

Timeline

Start date
2018-11-20
Primary completion
2020-11-19
Completion
2020-11-19
First posted
2019-11-22
Last updated
2022-08-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04173923. Inclusion in this directory is not an endorsement.